儿科指甲牛皮的超声波成像
Gabriel Castro Tavares1, Carolina Ávila de Almeida1, Sandra Valéria Coelho da Silva1
1Instituto de Puericultura e Pediatria Martagão Gesteira (IPPMG), Universidade Federal do Rio de Janeiro (UFRJ), Rio de Janeiro, Brazil.
Clinical imaging
|January 23, 2026
概括
儿科牛皮指甲的高频超声波 (US) 经常显示出三分之一以上的患者的亚临床异常和Power Doppler (PD) 活性,表明其在评估指甲疾病中的实用性.
科学领域:
- 儿科风湿病学 儿科风湿病学
- 皮肤病学 皮肤病学
- 医疗成像医学成像
背景情况:
- 儿科牛皮指甲的高频超声波 (US) 是一个尚未探索的领域.
- 牛皮通常影响儿童,影响指甲健康和生活质量.
研究的目的:
- 描述牛皮患者儿童的指甲US特征和Power Doppler (PD) 活动.
- 为了评估亚临床指甲异常的患病率,使用高频率US.
主要方法:
- 一项涉及43名儿科牛皮患者的横截面研究.
- 使用了一个具有敏感PD设置的18MHz美国探头.
- 评估了指甲板的不规则性,三层状的图案,沃茨曼分类和肠炎.
主要成果:
- 在46.5%的儿科患者中检测到美国的异常.
- 在37.2%观察到PD活性,包括临床正常的指甲.
- 三膜模式损失和沃茨曼型模式不常见;没有检测到肠炎.
结论:
- 高频指甲美国经常识别儿科牛皮的亚临床异常.
- 在超过三分之一的患者中,PD信号存在,肠道干涉最小.
- 研究结果支持小儿指甲的可行性,强调需要专门的参数和研究.
相关概念视频
Accessory Structures of the Skin: Nails
3.2K
Nails are one of the important accessory structures of the skin. They are hard, protective structures that cover the dorsal surface of the distal phalanges of fingers and toes. Nails are composed of specialized keratinized cells and serve various functions, including protection, sensation, and manual dexterity.
The main components of a nail include the following.
Nail Plate: The nail plate is the visible portion of the nail that extends beyond the fingertips or toes. It is a hard, translucent...
The main components of a nail include the following.
Nail Plate: The nail plate is the visible portion of the nail that extends beyond the fingertips or toes. It is a hard, translucent...
3.2K
Ultrasound II: Endoscopic Ultrasound and FibroScan
633
Endoscopic Ultrasound (EUS) and FibroScan are valuable diagnostic tools in gastroenterology and hepatology, each with specific applications and techniques.
Endoscopic Ultrasound (EUS):
Endoscopic Ultrasound (EUS):
633
Pharmacokinetics in Pediatric Patients: Drug Excretion
214
In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
214
Pharmacokinetics in Pediatric Patients: Drug Distribution
276
Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
276
Pharmacokinetics in Pediatric Patients: Drug Metabolism
200
In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
200
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption
261
Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
261


